Altayb, H.N.; Elbadawi, H.S.; Alzahrani, F.A.; Baothman, O.; Kazmi, I.; Nadeem, M.S.; Hosawi, S.; Chaieb, K.
Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of Klebsiella pneumoniae and Escherichia coli: A Genomic Approach. Pharmaceuticals 2022, 15, 1011.
https://doi.org/10.3390/ph15081011
AMA Style
Altayb HN, Elbadawi HS, Alzahrani FA, Baothman O, Kazmi I, Nadeem MS, Hosawi S, Chaieb K.
Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of Klebsiella pneumoniae and Escherichia coli: A Genomic Approach. Pharmaceuticals. 2022; 15(8):1011.
https://doi.org/10.3390/ph15081011
Chicago/Turabian Style
Altayb, Hisham N., Hana S. Elbadawi, Faisal A. Alzahrani, Othman Baothman, Imran Kazmi, Muhammad Shahid Nadeem, Salman Hosawi, and Kamel Chaieb.
2022. "Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of Klebsiella pneumoniae and Escherichia coli: A Genomic Approach" Pharmaceuticals 15, no. 8: 1011.
https://doi.org/10.3390/ph15081011
APA Style
Altayb, H. N., Elbadawi, H. S., Alzahrani, F. A., Baothman, O., Kazmi, I., Nadeem, M. S., Hosawi, S., & Chaieb, K.
(2022). Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of Klebsiella pneumoniae and Escherichia coli: A Genomic Approach. Pharmaceuticals, 15(8), 1011.
https://doi.org/10.3390/ph15081011